What the company actually pays, and whether its own cash supports it.
Dividends view
Yield
0.21%Below 5Y avg (0.30%)
Annual Rate
CNY 0.07Paid annual
Payout Ratio
12.8%Sustainable
Last Ex-Dividend
Sep 18, 2026
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
10.92BCNY
1.64B · vs all stocks (USD)
Updated Oct 23, 2026
Trailing P/E
29.86x
Updated Oct 23, 2026
Revenue (TTM)
2.33BCNY
349.09M · vs all stocks (USD)
Updated Oct 23, 2026
Profit Margin
14.51%
Updated Oct 23, 2026
Beta
0.5240x
vs all stocks
Updated Oct 23, 2026
52-Week Change
-23.05%
vs all stocks
Updated Oct 23, 2026
Market Capitalization
10.92BCNY
1.64B · vs all stocks (USD)
Updated Oct 23, 2026
Enterprise Value
9.32BCNY
1.40B · vs all stocks (USD)
Updated Oct 23, 2026
Trailing P/E
29.86x
Updated Oct 23, 2026
Forward P/E
24.38x
Updated Oct 23, 2026
Price to Sales (TTM)
4.38x
Provider-reported. Market Capitalization ÷ Revenue (TTM) on this page gives 4.69×.Updated Oct 23, 2026
Price to Book (MRQ)
3.80x
Updated Oct 23, 2026
Enterprise to Revenue
4.00x
Updated Oct 23, 2026
Enterprise to EBITDA
29.83x
Provider-reported. Enterprise Value ÷ EBITDA (TTM) on this page gives 27.81×.Updated Oct 23, 2026
Gross Margin
94.58%
Updated Oct 23, 2026
Profit Margin
14.51%
Updated Oct 23, 2026
Operating Margin
7.03%
Updated Oct 23, 2026
Return on Assets (TTM)
4.30%
Updated Oct 23, 2026
Return on Equity (TTM)
13.80%
Updated Oct 23, 2026
Revenue (TTM)
2.33BCNY
349.09M · vs all stocks (USD)
Updated Oct 23, 2026
Revenue per Share (TTM)
7.11CNYUpdated Oct 23, 2026
Quarterly Revenue Growth
7.60%
Updated Oct 23, 2026
Gross Profit (TTM)
2.18BCNY
327.67M · vs all stocks (USD)
Updated Oct 23, 2026
EBITDA (TTM)
334.97MCNY
50.24M · vs all stocks (USD)
Updated Oct 23, 2026
Net Income (TTM)
337.75MCNY
50.66M · vs all stocks (USD)
Updated Oct 23, 2026
Quarterly Earnings Growth (YoY)
33.00%
Updated Oct 23, 2026
Operating Cash Flow (TTM)
346.26MCNY
51.93M · vs all stocks (USD)
Updated Oct 23, 2026
Levered Free Cash Flow (TTM)
140.44MCNY
21.06M · vs all stocks (USD)
Updated Oct 23, 2026
Trailing Annual Dividend Rate
0.0750CNYUpdated Oct 23, 2026
Trailing Annual Dividend Yield
0.21%
vs all stocks
Updated Oct 23, 2026
5-Year Average Dividend Yield
0.30%
vs all stocks
Updated Oct 23, 2026
Payout Ratio
12.85%
Provider-reported. Trailing Annual Dividend Rate ÷ Diluted EPS (TTM) on this page gives 6.76%.Updated Oct 23, 2026
Revenue
2.29BCNYFY2025 · Dec 31, 2025
Cost of Goods Sold
143.03MCNYFY2025 · Dec 31, 2025
Gross Profit
2.14BCNYFY2025 · Dec 31, 2025
Operating Income
274.29MCNY
41.14M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Pre-tax Income
290.65MCNYFY2025 · Dec 31, 2025
Income Tax Expense
1.95MCNYFY2025 · Dec 31, 2025
Net Income
288.69MCNYFY2025 · Dec 31, 2025
EBIT
290.86MCNYFY2025 · Dec 31, 2025
EBITDA (Income Statement)
334.97MCNYFY2025 · Dec 31, 2025
Research & Development
307.20MCNYFY2025 · Dec 31, 2025
Selling, General & Administrative
1.37BCNYFY2025 · Dec 31, 2025
Other Operating Expenses
18.80MCNYFY2025 · Dec 31, 2025
Non-operating Interest Income
33.90MCNYFY2025 · Dec 31, 2025
Non-operating Interest Expense
211.64KCNYFY2025 · Dec 31, 2025
EPS (Basic)
0.9500CNYFY2025 · Dec 31, 2025
EPS (Diluted)
0.9500CNYFY2025 · Dec 31, 2025
Basic Shares Outstanding
303.89MSharesFY2025 · Dec 31, 2025
Diluted Shares Outstanding
303.89MSharesFY2025 · Dec 31, 2025
Net Income from Continuing Operations
288.69MCNYFY2025 · Dec 31, 2025
Preferred Stock Dividends
0.00CNYFY2025 · Dec 31, 2025
Operating Cash Flow
230.30MCNYFY2025 · Dec 31, 2025
Free Cash Flow
139.13MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents (End of Period)
123.25MCNYFY2025 · Dec 31, 2025
Starting Profit (CF Statement)
288.69MCNYFY2025 · Dec 31, 2025
Other Non-cash Items
-30.96MCNYFY2025 · Dec 31, 2025
Change in Accounts Receivable (CF)
-17.77MCNYFY2025 · Dec 31, 2025
Change in Other Assets/Liabilities
-9.67MCNYFY2025 · Dec 31, 2025
Capital Expenditures
-91.17MCNYFY2025 · Dec 31, 2025
Purchase of Investments
-2.53BCNYFY2025 · Dec 31, 2025
Sale of Investments
2.86BCNYFY2025 · Dec 31, 2025
Other Investing Activity
-587.72MCNYFY2025 · Dec 31, 2025
Net Investing Cash Flow
-351.46MCNYFY2025 · Dec 31, 2025
Common Dividends Paid
-38.71MCNYFY2025 · Dec 31, 2025
Other Financing Charges
-2.95MCNYFY2025 · Dec 31, 2025
Net Financing Cash Flow
-41.66MCNYFY2025 · Dec 31, 2025
Shares Outstanding
307.64MSharesUpdated Oct 23, 2026
Float Shares
147.12MSharesUpdated Oct 23, 2026
% Held by Insiders
57.85%
vs all stocks
Updated Oct 23, 2026
% Held by Institutions
4.81%
vs all stocks
Updated Oct 23, 2026
Total Cash (MRQ)
887.70MCNY
133.14M · vs all stocks (USD)
Updated Oct 23, 2026
Total Cash per Share (MRQ)
2.89CNYUpdated Oct 23, 2026
Total Debt (MRQ)
4.85MCNY
728.02K · vs all stocks (USD)
Updated Oct 23, 2026
Total Debt to Equity (MRQ)
0.0018x
Updated Oct 23, 2026
Current Ratio (MRQ)
1.18x
Updated Oct 23, 2026
Book Value per Share (MRQ)
8.71CNYUpdated Oct 23, 2026
Total Assets
4.21BCNY
631.84M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Total Current Assets
2.53BCNYFY2025 · Dec 31, 2025
Total Liabilities
1.79BCNYFY2025 · Dec 31, 2025
Total Non-current Assets
1.69BCNYFY2025 · Dec 31, 2025
Total Non-current Liabilities
6.61MCNYFY2025 · Dec 31, 2025
Total Current Liabilities
1.78BCNYFY2025 · Dec 31, 2025
Cash
843.20MCNYFY2025 · Dec 31, 2025
Cash Equivalents
12.56MCNYFY2025 · Dec 31, 2025
Cash & Cash Equivalents
855.76MCNYFY2025 · Dec 31, 2025
Other Short-term Investments
645.10MCNYFY2025 · Dec 31, 2025
Accounts Receivable
283.02MCNYFY2025 · Dec 31, 2025
Inventory
73.16MCNYFY2025 · Dec 31, 2025
Accounts Payable
605.65MCNYFY2025 · Dec 31, 2025
Short-term Debt
1.78MCNYFY2025 · Dec 31, 2025
Other Current Liabilities
84.03MCNYFY2025 · Dec 31, 2025
Long-term Debt
2.29MCNYFY2025 · Dec 31, 2025
Common Stock (Book)
260.60MCNYFY2025 · Dec 31, 2025
Retained Earnings
1.62BCNYFY2025 · Dec 31, 2025
Total Shareholders' Equity
2.43BCNY
363.82M · vs all stocks (USD)
FY2025 · Dec 31, 2025
Treasury Stock
251.34MCNYFY2025 · Dec 31, 2025
52-Week Low
28.10CNYUpdated Oct 23, 2026
52-Week High
62.09CNYUpdated Oct 23, 2026
52-Week Change
-23.05%
vs all stocks
Updated Oct 23, 2026
Beta
0.5240x
vs all stocks
Updated Oct 23, 2026
50-Day MA
37.58CNYUpdated Oct 23, 2026
200-Day MA
39.23CNYUpdated Oct 23, 2026
Avg 10-Day Volume
8.64MSharesUpdated Oct 23, 2026
Avg 30-Day Volume
11.75MSharesUpdated Oct 23, 2026
Diluted EPS (TTM)
1.11CNYUpdated Oct 23, 2026
2 interpretations currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Almost nothing is lost between its operating profit and its net income.
Reads
Where is this company structurally exposed?
Ulcer Index Elevated, Drawdown From Peak Significant, 20-Week Volatility Elevated
It sits well below its peak, and the fall has been both deep and long.
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 5.19: safe zoneNotable
Altman Z-Score: 5.19
Supply Chain
Downstream position: depends on 10 industries, supplies 5Notable
Outgoing: 5.00Incoming: 10.00
High connectivity hub: 15 industry connectionsNotable
Total Connections: 15.00
Scale
Market cap is $1.64B, above the global median of $1.14BNotable
Market cap (USD): 1,637,037,234.262Global Median: 1,137,180,293.291
Levered free cash flow is $21.06M, above the global median of $18.58MNotable